Jim Cramer's 'Mad Money' CEO Chats: Cheniere Energy and Walgreen
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener .
NEW YORK ( TheStreet) -- Every night, Jim Cramer sits down with CEOs and executives on his "Mad Money" show to discuss their business, the economy, politics and more. Today we look back at his recent interviews with Charif Souki of Cheniere Energy
These are excerpts from Cramer's 'Mad Money' Recap, originally published on Jan. 8 and Jan. 14, 2014.
Executive Decision: Charif Souki
For his "Executive Decision" segment, Cramer sat down Charif Souki, chairman, president and CEO of Cheniere Energy, the company building two export terminals to take advantage of America's growing abundance of natural gas.
Souki said Cheniere is now giving investors multiple ways to invest -- with the original Cheniere shares, trading under the ticker LNG, along with Cheniere Energy Partners
When asked whether the demand for natural gas is slowing, Souki said there is an unlimited number of potential customers for Cheneire as long as there's such a large price differential between gas and oil. Our country still burns off more excess oil through flaring than it uses, Souki noted.
When will America wake up and embrace its own natural resource? Souki said the markets are moving in that direction and it's better to let them progress naturally rather than force a change through legislation.
Finally, when asked about competition, Souki said that no one but Cheniere has broken ground on an export terminal, giving his company a huge first-mover advantage.
Cramer continued his recommendation of Cheniere.
Executive Decision: Greg Wasson
In his "Executive Decision" segment, Cramer spoke with Greg Wasson, president and CEO of Walgreen, our nation's largest drugstore chain with 8,500 locations. Shares of Walgreen were up 58% last year.
Wasson said Walgreen's goal is to take on a greater role in providing convenient health care to the public. In addition to pharmacists dispensing medications, Walgreen is also adding in-store nurses to offer vaccinations, screenings and even treat common ear aches and sore throats.
Walgreen is also about value, Wasson noted, which is why the company introduced over 2,000 private-label items last year. Consumers remain cautious, he said, and are looking for more value from brands they trust.
Wasson said over 63% of the American population now lives within five miles of a Walgreen's, which means that more than any other brand, the company is positioned to achieve its goals. The company also has a growing international presence thanks to its acquisition of Alliance Boots, which operates in 25 countries.
Cramer said Walgreen remains a terrific story that is executing perfectly.